Home 2023

Sickle cell disease

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease
Genome Editing

Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease

Kathy Vuksanaj -
0
Editas Medicine and Azzur Group Expand Biomanufacturing Partnership
Bioprocessing

Editas Medicine and Azzur Group Expand Biomanufacturing Partnership

John Sterling -
0
Base Editing Beats Other Genome Editing Strategies for Treating Sickle Cell Disease
Genome Editing

Base Editing Beats Other Genome Editing Strategies for Treating Sickle Cell Disease

Julianna LeMieux, PhD -
0
Base Editors and Prime Editors Begin to Realize Their Clinical Promise
Genome Editing

Base Editors and Prime Editors Begin to Realize Their Clinical Promise

Kathy Vuksanaj -
1
Gene Therapy from Editas Shows Promise in Early Sickle Cell Trial
Infectious Diseases

Gene Therapy from Editas Shows Promise in Early Sickle Cell Trial

John Sterling -
0
ASGCT News: David Liu Hails Rapid Progress in Precision Genome Editing
Genome Editing

ASGCT News: David Liu Hails Rapid Progress in Precision Genome Editing

Kathy Vuksanaj -
35
ASGCT News: Hematologist David Williams Wins 2023 ASGCT Founder’s Award
Genome Editing

ASGCT News: Hematologist David Williams Wins 2023 ASGCT Founder’s Award

Kathy Vuksanaj -
0
Molecular Scissors Are Making the Cut … in Clinical Trials
Genome Editing

Molecular Scissors Are Making the Cut … in Clinical Trials

Kathy Vuksanaj -
0
Prime-Edited Patient Blood Stem Cells Fully Engraft and Rescue Sickle Cell Mice
Genome Editing

Prime-Edited Patient Blood Stem Cells Fully Engraft and Rescue Sickle Cell Mice

Jonathan D Grinstein, PhD -
0
123...9Page 1 of 9
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.